瑞银（UBS）首次覆盖Inspire Medical Systems，给予“卖出”评级，与之前的“中性”评级形成对照；其设定的目标价为39美元，而此前目标价为67美元。
瑞银（UBS）首次覆盖Inspire Medical Systems，给予“卖出”评级，与之前的“中性”评级形成对照；其设定的目标价为39美元，而此前目标价为67美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.